Related references
Note: Only part of the references are listed.Long non-coding RNA MAGI2-AS3 inhibits breast cancer cell migration and invasion via sponging microRNA-374a
Shanmei Du et al.
CANCER BIOMARKERS (2019)
Breast Cancer Treatment
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness
Vivian Yvonne Shin et al.
CELL DEATH & DISEASE (2019)
Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity
Zhongqiu Zheng et al.
MEDICAL SCIENCE MONITOR (2019)
The Regulatory Roles of Long Non-Coding RNA in the Chemoresistance Process of Ovarian cancer
Jiayuan Qu et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition
Hao Ye et al.
BIOMATERIALS (2019)
Expression of long noncoding RNAs in breast cancer in relation to reproductive factors and tumor characteristics
Soudeh Ghafouri-Fard et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer
Gan Yu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers
Alex J. Gooding et al.
ONCOGENE (2019)
Penfluridol overcomes paclitaxel resistance in metastatic breast cancer
Nehal Gupta et al.
SCIENTIFIC REPORTS (2019)
Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes
Shunheng Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer
Yiran Liang et al.
CANCER BIOLOGY & THERAPY (2018)
TFF1 and TFF3 mRNAs Are Higher in Blood from Breast Cancer Patients with Metastatic Disease than Those without
Marwa H. Elnagdy et al.
JOURNAL OF ONCOLOGY (2018)
Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant Check triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway
Jiguang Han et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer
Grant R. Howard et al.
SCIENTIFIC REPORTS (2018)
lncRNA profile study reveals the mRNAs and lncRNAs associated with docetaxel resistance in breast cancer cells
Peide Huang et al.
SCIENTIFIC REPORTS (2018)
Identification of an lncRNA-miRNA-mRNA interaction mechanism in breast cancer based on bioinformatic analysis
Yuhan Zhang et al.
MOLECULAR MEDICINE REPORTS (2017)
Increased cell survival and cytogenetic integrity by spatial dose redistribution at a compact synchrotron X-ray source
Karin Burger et al.
PLOS ONE (2017)
Long noncoding RNA and mRNA profiling in MDA-MB-231 cells following RNAi-mediated knockdown of SIRT7
Kun-Lin Chen et al.
ONCOTARGETS AND THERAPY (2017)
ABCG2-overexpressing H460/MX20 cell xenografts in athymic nude mice maintained original biochemical and cytological characteristics
Wei Zhang et al.
SCIENTIFIC REPORTS (2017)
Clinical Practice Guidelines on the Evidence-Based Use of Integrative Therapies During and After Breast Cancer Treatment
Heather Greenlee et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts
A. Tankiewicz-Kwedlo et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression
Yashar S. Niknafs et al.
NATURE COMMUNICATIONS (2016)
Trefoil factor 3 (TFF3) enhances the oncogenic characteristics of prostate carcinoma cells and reduces sensitivity to ionising radiation
Omesha Perera et al.
CANCER LETTERS (2015)
TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer
Felicity E. B. May et al.
ENDOCRINE-RELATED CANCER (2015)
Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer
Philip Jonsson et al.
MOLECULAR ENDOCRINOLOGY (2015)
Breast Cancer Statistics, 2013
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
CCAAT/Enhancer Binding Protein β (C/EBPβ) Isoforms as Transcriptional Regulators of the Pro-Invasive CDH3/P-Cadherin Gene in Human Breast Cancer Cells
Andre Albergaria et al.
PLOS ONE (2013)
TFF3 Is a Normal Breast Epithelial Protein and Is Associated with Differentiated Phenotype in Early Breast Cancer but Predisposes to Invasion and Metastasis in Advanced Disease
Ahmed R. H. Ahmed et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
G. M. A. Ajabnoor et al.
CELL DEATH & DISEASE (2012)
The Emergence of lncRNAs in Cancer Biology
John R. Prensner et al.
CANCER DISCOVERY (2011)
Establishment of a Paclitaxel Resistant Human Breast Cancer Cell Strain (MCF-7/Taxol) and Intracellular Paclitaxel Binding Protein Analysis
K-Q Zuo et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models
Abhik Bandyopadhyay et al.
PLOS ONE (2010)
Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML
Jason A. Powell et al.
BLOOD (2009)
C/EBPβ induces chromatin opening at a cell-type-specific enhancer
Annette Plachetka et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Transcriptional control of TFF3 (intestinal trefoil factor) via promoter binding sites for the nuclear factor κB and C/EBPβ
M Baus-Loncar et al.
PEPTIDES (2004)
Expression of the CCAAT/enhancer-binding proteins C/EBPα, C/EBPβ and C/EBPδ in breast cancer:: correlations with clinicopathologic parameters and cell-cycle regulatory proteins
K Milde-Langosch et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
CCAAT/enhancer binding proteins in normal mammary development and breast cancer
CA Zahnow
BREAST CANCER RESEARCH (2002)
Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance
NJ Turton et al.
ONCOGENE (2001)
Share Paper
